跳至主要内容
临床试验/IRCT20110423006257N3
IRCT20110423006257N3招募中3 期

A clinical trial to evaluate the therapeutic effects of thalidomide in patients with COVID-19 infection

Arak University of Medical Sciences0 个研究点目标入组 66 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
66

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 80 years(—)
性别
All

入选标准

  • Duration of the symptoms less than 10 days
  • Lymphocyte count less than 1000 per microliter
  • Quantitative CRP more than 1.5 times normal
  • Positive pcr test of covid 19
  • O2 sat less than 93%
  • Respiratory rate less than 24
  • Chest CT scan findings compatible with COVID-19 Pneumonia

排除标准

  • History of chronic disease
  • Pregnant women, lactating women , sexually active premenopausal women
  • Loss of consciousness
  • Liver enzymes more than 5 times normal

研究者

相似试验